Drug Safety Newsletter 41st Edition
09 May 2011
Topics covered in this edition of the newsletter include:
- Paracetamol - Available evidence does not support a causal relationship with asthma in children after exposure in pregnancy or use in early infancy
- Provigil (Modafinil) – EU wide restriction of use and updated recommendations to support safer use
- Tygacil (tigecycline) – recommendations for use
- Efient (prasugrel) – reports of hypersensitivity reactions
- Revlimid (lenalidomide) – risk of venous and arterial thromboembolic events
- Direct Healthcare Professional Communications published on the IMB website since the last drug Safety Newsletter
Drug Safety Newsletter 41st Edition